Paper34066917
Ixekizumab May Improve Renal Function in Psoriasis.
Amoruso GF and 6 others. Healthcare (Basel), 2021. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Ixekizumab May Improve Renal Function in Psoriasis. Papers, record 34066917. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34066917
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33141869 | Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study. | PLoS One | 2020 | https://conductscience.org/library/papers/33141869 | PubMed |
| 2 | 29140820 | Renal effects of cytokines in hypertension. | Curr Opin Nephrol Hypertens | 2018 | https://conductscience.org/library/papers/29140820 | PubMed |
| 3 | 33383665 | Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis. | J Pers Med | 2020 | https://conductscience.org/library/papers/33383665 | PubMed |
| 4 | 19820122 | Th1 and Th17 cells induce proliferative glomerulonephritis. | J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19820122 | PubMed |
| 5 | 25292347 | Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease. | Rheumatol Int | 2015 | https://conductscience.org/library/papers/25292347 | PubMed |
| 6 | 30295379 | Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review. | Dermatol Ther | 2018 | https://conductscience.org/library/papers/30295379 | PubMed |
| 7 | 33141505 | Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising. | Dermatol Ther | 2020 | https://conductscience.org/library/papers/33141505 | PubMed |
| 8 | 26949177 | Biologics for the treatment of autoimmune renal diseases. | Nat Rev Nephrol | 2016 | https://conductscience.org/library/papers/26949177 | PubMed |
| 9 | 31694234 | Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis. | Children (Basel) | 2019 | https://conductscience.org/library/papers/31694234 | PubMed |
| 10 | 32942670 | Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis. | Medicina (Kaunas) | 2020 | https://conductscience.org/library/papers/32942670 | PubMed |
| 11 | 31762153 | Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report. | Dermatol Ther | 2020 | https://conductscience.org/library/papers/31762153 | PubMed |
| 12 | 30733983 | An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis. | JAAD Case Rep | 2019 | https://conductscience.org/library/papers/30733983 | PubMed |
| 13 | 33419370 | Pharmacogenetics Update on Biologic Therapy in Psoriasis. | Medicina (Kaunas) | 2020 | https://conductscience.org/library/papers/33419370 | PubMed |
| 14 | 20100727 | Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. | Nephrol Dial Transplant | 2010 | https://conductscience.org/library/papers/20100727 | PubMed |
| 15 | 33050592 | New Treatment Addressing the Pathogenesis of Psoriasis. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33050592 | PubMed |
| 16 | 25887118 | IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment. | BMC Immunol | 2015 | https://conductscience.org/library/papers/25887118 | PubMed |
| 17 | 31572188 | Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31572188 | PubMed |
| 18 | 31881298 | Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease. | J Am Acad Dermatol | 2020 | https://conductscience.org/library/papers/31881298 | PubMed |
| 19 | 33066228 | Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility? | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33066228 | PubMed |
| 20 | 31963845 | Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy? | J Clin Med | 2020 | https://conductscience.org/library/papers/31963845 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40285915 | Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice. | J Mol Histol | 2025 | https://conductscience.org/library/papers/40285915 | PubMed |
| 39254877 | The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39254877 | PubMed |
| 35888704 | Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis-Preliminary Data. | Metabolites | 2022 | https://conductscience.org/library/papers/35888704 | PubMed |
| 35682382 | Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35682382 | PubMed |
| 35629363 | Dextromethorphan Exhibits Anti-Inflammatory and Immunomodulatory Effects in a Murine Model: Therapeutic Implication in Psoriasis. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35629363 | PubMed |
| 35625795 | Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625795 | PubMed |
| 35563374 | Transcriptomic Profiling of Peripheral Edge of Lesions to Elucidate the Pathogenesis of Psoriasis Vulgaris. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563374 | PubMed |
| 35456720 | Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456720 | PubMed |
| 35407618 | Degenerative and Inflammatory Osteoproliferations in Lumbar Radiographs in Psoriatic Arthritis Patients. | J Clin Med | 2022 | https://conductscience.org/library/papers/35407618 | PubMed |
| 35268344 | Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life. | J Clin Med | 2022 | https://conductscience.org/library/papers/35268344 | PubMed |
| 35214027 | Colchicine in Managing Skin Conditions: A Systematic Review. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35214027 | PubMed |
| 35163233 | The Role of Podoplanin in Skin Diseases. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163233 | PubMed |
| 35054504 | Transcriptional Analysis-Based Alterations Affecting Neuritogenesis of the Peripheral Nervous System in Psoriasis. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35054504 | PubMed |
| 34945136 | Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. | J Clin Med | 2021 | https://conductscience.org/library/papers/34945136 | PubMed |
| 34834393 | Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834393 | PubMed |
| 34827121 | Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus-Preliminary Data. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/34827121 | PubMed |
| 34638740 | Psoriasis and Atherosclerosis-Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638740 | PubMed |
| 34571998 | Compositional Features of Distinct Microbiota Base on Serum Extracellular Vesicle Metagenomics Analysis in Moderate to Severe Psoriasis Patients. | Cells | 2021 | https://conductscience.org/library/papers/34571998 | PubMed |
| 34502197 | The Role of Epigenetic Factors in Psoriasis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502197 | PubMed |
| 34442396 | The Impact of Smoking on Psoriasis Patients with Biological Therapies in a Bucharest Hospital. | J Pers Med | 2021 | https://conductscience.org/library/papers/34442396 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL17A | 3605 | PubTator's text mining | https://conductscience.org/library/genes/3605 | NCBI Gene |
| IL17F | 112744 | PubTator's text mining | https://conductscience.org/library/genes/112744 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL23A | 51561 | PubTator's text mining | https://conductscience.org/library/genes/51561 | NCBI Gene |
| SLC17A5 | 26503 | PubTator's text mining | https://conductscience.org/library/genes/26503 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34066917
GET https://conductscience.org/api/papers/v1/34066917/references?page=2